The United States Food and Drug Administration (FDA) stopped the authorization for the emergency use of blood plasma from patients who have overcome covid-19. According to The New York Times, the FDA's decision comes after reputable experts argued the lack of sufficient data.
USA: stop the use of plasma in patients recovered from covid-19
2020-08-19T21:34:19.804Z
The US Food and Drug Administration (FDA) stopped the authorization for the emergency use of blood plasma from patients who passed the voc ...